QMS MEDICAL ALLIED S LTD (QMSMEDI) financials

QMS MEDICAL ALLIED S LTD (QMSMEDI) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Market Cap: ₹342Cr.
Current Price: ₹177
Stock P/E: 52.4
ROE: 6.96%
ROCE: 9.62%
Book Value: ₹53.9
Dividend Yield: 0.28%
52W High / Low: ₹217/69.0

In Jun 2026, QMS MEDICAL ALLIED S LTD (QMSMEDI) reported sales ₹52.34 Cr and net profit ₹2.67 Cr.

Annual TTM: sales ₹162 Cr, net profit ₹7 Cr.

Shareholding: Promoters 68.11% (Sep 2026), FIIs 0.41% (Sep 2026), DIIs 1.30% (Sep 2026), Public 30.17% (Sep 2026), No. of Shareholders 2,437% (Sep 2026).

QMSMEDI quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	32.74	39.38	42.38	42.32	41.25	29.54	39.19	52.34
Expenses	27.41	34.04	34.56	35.99	35.12	25.77	34.80	45.34
Operating Profit	5.33	5.34	7.82	6.33	6.13	3.77	4.39	7.00
OPM %	16.28%	13.56%	18.45%	14.96%	14.86%	12.76%	11.20%	13.37%
Other Income	0.09	0.12	0.13	0.15	0.00	0.13	0.07	0.25
Interest	1.07	1.31	2.73	1.77	1.73	2.06	2.38	2.05
Depreciation	0.83	0.91	0.90	0.83	0.83	0.92	1.22	1.31
Profit before tax	3.52	3.24	4.32	3.88	3.57	0.92	0.86	3.89
Tax %	25.85%	27.47%	29.17%	30.93%	26.05%	36.96%	27.91%	31.36%
Net Profit	2.61	2.35	3.07	2.68	2.64	0.58	0.63	2.67
EPS in Rs	1.35	1.22	1.59	1.39	1.37	0.30	0.33	1.38
Raw PDF	—	—	—	—	—	—	—	—

QMSMEDI profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	73	122	146	104	122	145	152	162
Expenses	63	105	130	93	104	121	132	141
Operating Profit	10	17	17	11	18	23	20	21
OPM %	13%	14%	11%	11%	15%	16%	13%	13%
Other Income	0	0	1	1	0	0	0	0
Interest	1	1	2	2	3	6	8	8
Depreciation	0	1	1	1	3	3	4	4
Profit before tax	9	15	14	9	12	14	9	9
Tax %	28%	27%	26%	27%	26%	28%	29%	—
Net Profit	6	11	11	6	9	10	7	7
EPS in Rs	3.85	6.66	6.52	3.31	4.66	5.40	3.46	3.38
Dividend Payout %	0%	0%	0%	0%	10%	86%	145%	—

QMSMEDI balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.01	3	4	4	18	18	18	19
Reserves	3	6	17	27	53	61	70	85
Borrowings	5	12	20	32	26	2	77	91
Other Liabilities	10	12	20	19	22	54	24	25
Total Liabilities	18	33	60	82	118	135	189	220
Fixed Assets	0	3	10	8	25	24	22	25
CWIP	0	0	0	0	1	2	3	3
Investments	0	0	0	0	0	2	48	63
Other Assets	18	30	50	75	91	108	115	130
Total Assets	18	33	60	82	118	135	189	220

QMSMEDI cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	0	4	2	-2	-8	1	26	19
Cash from Investing Activity	-0	-4	-8	2	-25	-2	-49	-18
Cash from Financing Activity	0	0	7	0	32	-1	23	-1
Net Cash Flow	0	1	1	1	-1	-1	0	-0
Free Cash Flow	0	1	-6	-2	-9	1	26	19
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	34%	44%	34%	11%	-47%	26%	130%	105%

QMSMEDI shareholding pattern (%)
Category	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	73.67%	73.67%	73.67%	73.67%	68.11%	68.11%	68.11%	68.11%
FIIs	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.41%
DIIs	0.00%	0.00%	0.00%	0.00%	1.60%	1.59%	1.59%	1.30%
Public	26.33%	26.33%	26.33%	26.33%	30.28%	30.30%	30.30%	30.17%
No. of Shareholders	1,586	1,695	1,519	1,489	1,564	1,499	1,554	2,437

QMSMEDI key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	56	56	69	105	137	124	136	142
Inventory Days	76	108	82	80	140	172	176	191
Days Payable	75	78	73	56	91	90	74	75
Cash Conversion Cycle	58	86	77	129	187	205	238	258
Working Capital Days	20	27	28	57	138	244	93	85
ROCE %	121%	65%	54%	30%	14%	17%	17%	10%

QMSMEDIUpdated 21 Oct 2026, 1:43

Qms Medical Allied S Ltd

QMSMEDIUpdated 21 Oct 2026, 1:43

Market Cap

₹342Cr.

Current Price

₹177

High / Low

₹217/69.0

Stock P/E

52.4

ROE6.96%

ROCE9.62%

Book Value₹53.9

Face Value₹10.0

Dividend Yield0.28%

About

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	25.96	0.59	21.3	0.08	0.82	3.33	26.13	2.46	1.27
Sep 2023	28.64	0.74	23.74	0.11	0.86	3.41	25.22	2.56	1.33
Dec 2023	35.24	0.81	30.4	0.15	0.88	3.3	25.76	2.44	1.26
Mar 2024	32.29	0.99	28.34	0.11	0.88	2.19	29.68	1.54	0.8
Jun 2024	30.37	0.84	25.53	0.11	0.77	3.34	28.44	2.4	1.24
Sep 2024	32.74	1.07	27.41	0.09	0.83	3.52	25.85	2.61	1.35
Dec 2024	39.38	1.31	34.04	0.12	0.91	3.24	27.47	2.35	1.22
Mar 2025	42.38	2.73	34.56	0.13	0.9	4.32	29.17	3.07	1.59
Jun 2025	42.32	1.77	35.99	0.15	0.83	3.88	30.93	2.68	1.39
Sep 2025	41.25	1.73	35.12	0	0.83	3.57	26.05	2.64	1.37
Dec 2025	29.54	2.06	25.77	0.13	0.92	0.92	36.96	0.58	0.3
Mar 2026	39.19	2.38	34.8	0.07	1.22	0.86	27.91	0.63	0.33
Jun 2026	52.34	2.05	45.34	0.25	1.31	3.89	31.36	2.67	1.38

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2018	0	0	0	0	0	0	0	0	—
Mar 2019	52	0	47	0	0	4	30	3	—
Mar 2020	73	1	63	0	0	9	28	6	3.85
Mar 2021	122	1	105	0	1	15	27	11	6.66
Mar 2022	146	2	130	1	1	14	26	11	6.52
Mar 2023	104	2	93	1	1	9	27	6	3.31
Mar 2024	122	3	104	0	3	12	26	9	4.66
Mar 2025	145	6	121	0	3	14	28	10	5.4
Mar 2026	152	8	132	0	4	9	29	7	3.46
TTM	162	8	141	0	4	9	—	7	3.38

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	68.11%
FIIs	0.41%
DIIs	1.3%
Public	30.17%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2022	73.67%	0.71%	0%	25.62%
Mar 2023	73.67%	1.21%	0%	25.12%
Sep 2023	73.67%	1.02%	0%	25.32%
Mar 2024	73.67%	0.01%	0%	26.33%
Sep 2024	73.67%	0.01%	0%	26.33%
Mar 2025	73.67%	0.01%	0%	26.33%
Jun 2025	73.67%	0.01%	0%	26.33%
Sep 2025	68.11%	0.01%	1.6%	30.28%
Mar 2026	68.11%	0%	1.59%	30.3%
Jun 2026	68.11%	0%	1.59%	30.3%
Sep 2026	68.11%	0.41%	1.3%	30.17%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2018	0.01	0	0	5	5	0	0	0	5	5
Mar 2019	0.01	3	5	10	18	0	0	0	18	18
Mar 2020	3	6	12	12	33	3	0	0	30	33
Mar 2021	4	17	20	20	60	10	0	0	50	60
Mar 2022	4	27	32	19	82	8	0	0	75	82
Mar 2023	18	53	26	22	118	25	1	0	91	118
Mar 2024	18	61	2	54	135	24	2	2	108	135
Mar 2025	18	70	77	24	189	22	3	48	115	189
Mar 2026	19	85	91	25	220	25	3	63	130	220

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2018	0	0	0	0
Mar 2019	0	0	0	0
Mar 2020	4	-4	0	1
Mar 2021	2	-8	7	1
Mar 2022	-2	2	0	1
Mar 2023	-8	-25	32	-1
Mar 2024	1	-2	-1	-1
Mar 2025	26	-49	23	0
Mar 2026	19	-18	-1	0

Key ratios

Historical financial ratios

Category	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	411	56	56	69	105	137	124	136	142
Inventory Days	22,891	76	108	82	80	140	172	176	191
Days Payable	26,124	75	78	73	56	91	90	74	75
Cash Conversion Cycle	-2,822	58	86	77	129	187	205	238	258
Working Capital Days	-91	20	27	28	57	138	244	93	85
ROCE %	—	121%	65%	54%	30%	14%	17%	17%	10%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of QMS MEDICAL ALLIED S LTD (QMSMEDI)?

The reported market capitalisation for QMS MEDICAL ALLIED S LTD (QMSMEDI) is ₹342Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of QMSMEDI?

The current price shown for QMS MEDICAL ALLIED S LTD (QMSMEDI) on Fincrux is ₹177 with a 52-week high/low of ₹217/69.0.

What is the P/E ratio of QMS MEDICAL ALLIED S LTD (QMSMEDI)?

The stock P/E for QMS MEDICAL ALLIED S LTD (QMSMEDI) is 52.4 on Fincrux, with ROE at 6.96% and ROCE at 9.62%.

What were QMSMEDI latest quarterly results?

For Jun 2026, QMS MEDICAL ALLIED S LTD (QMSMEDI) reported sales ₹52.34 Cr and net profit ₹2.67 Cr (figures in ₹ crore unless noted).

What are QMSMEDI annual sales and net profit?

For TTM, QMS MEDICAL ALLIED S LTD (QMSMEDI) shows sales of ₹162 Cr and net profit of ₹7 Cr on the Fincrux profit & loss statement.

Who owns QMS MEDICAL ALLIED S LTD (QMSMEDI)?

Latest shareholding for QMS MEDICAL ALLIED S LTD (QMSMEDI) on Fincrux: Promoters 68.11% (Sep 2026), FIIs 0.41% (Sep 2026), DIIs 1.30% (Sep 2026), Public 30.17% (Sep 2026), No. of Shareholders 2,437% (Sep 2026).

Where can I find QMS MEDICAL ALLIED S LTD (QMSMEDI) financials?

QMS MEDICAL ALLIED S LTD (QMSMEDI) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show QMSMEDI balance sheet and cash flow?

Yes. The QMS MEDICAL ALLIED S LTD (QMSMEDI) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 21 October 2026 at 1:43